Related Experiment Videos

Further evidence supporting the concurrent influence of aflatoxin and manganese

Veterinary and Human Toxicology
|April 1, 1987
PubMed

Insights

Manganese (Mn) may protect against aflatoxin B1 (AFB1) toxicity. Studies show AFB1 alters Mn excretion and retention in rats, suggesting a significant biointeraction between these substances.

Area of Science:

  • Toxicology
  • Biochemistry
  • Nutritional Science

Background:

  • Aflatoxin B1 (AFB1) is a toxic compound produced by Aspergillus fungi.
  • Trace elements, such as manganese (Mn), play crucial roles in cellular processes and may influence detoxification pathways.

Purpose of the Study:

  • To investigate the potential protective role of manganese against the toxic effects of aflatoxin B1.
  • To examine the biointeraction between manganese and aflatoxin B1 in vivo.

Main Methods:

  • Young male Fischer rats were administered varying doses of aflatoxin B1 (AFB1) via intraperitoneal injection.
  • Rats received radiolabeled manganese ([54Mn]-MnCl2) via gavage 12 hours post-AFB1 injection.
  • Total body radioactivity and body weight changes were monitored over 72 hours post-radiolabel administration.

Main Results:

  • Aflatoxin B1 exposure significantly altered the excretion and retention of manganese in rats.
  • Higher doses of AFB1 led to increased initial manganese excretion followed by enhanced conservation of the metal at later time points.
  • Aflatoxicosis was associated with reduced body weight gain in the treated animals.

Conclusions:

  • The study provides evidence for a significant biointeraction between manganese and aflatoxin B1.
  • Manganese metabolism is affected by AFB1 exposure, suggesting a potential role in aflatoxin toxicity or detoxification.

Related Concept Videos